Myocardial infarction (within 30‐days after surgery: sudden death or death resulting from a primarily identifiable cardiac cause) · adults undergoing cardiac surgery
Alpha‐2 adrenergic agonists showed no clear difference in myocardial infarction (within 30‐days after surgery: sudden death or… compared with control (moderate certainty).
1 finding from 1 review
All‐cause mortality (30 days)—cardiac surgery · patients with coronary heart disease and/or valvular heart disease
Beta‐blocker showed no clear difference in all‐cause mortality (30 days)—cardiac surgery compared with control—cardiac surgery (moderate certainty).
1 finding from 1 review
Acute myocardial infarction—cardiac surgery · patients with coronary heart disease and/or valvular heart disease
Beta‐blocker showed no clear difference in acute myocardial infarction—cardiac surgery compared with control—cardiac surgery (moderate certainty).
1 finding from 1 review
Cerebrovascular events—cardiac surgery · patients with coronary heart disease and/or valvular heart disease
Beta‐blocker showed no clear difference in cerebrovascular events—cardiac surgery compared with control—cardiac surgery (low certainty).
1 finding from 1 review
Ventricular arrhythmias—cardiac surgery ECG · patients with coronary heart disease and/or valvular heart disease
Beta‐blocker probably leads to lower ventricular arrhythmias—cardiac surgery ECG compared with control—cardiac surgery (moderate certainty).
1 finding from 1 review
All supraventricular arrhythmias—cardiac surgery ECG · patients with coronary heart disease and/or valvular heart disease
Beta‐blocker leads to lower all supraventricular arrhythmias—cardiac surgery ECG compared with control—cardiac surgery (high certainty).
1 finding from 1 review
Bradycardia · patients with coronary heart disease and/or valvular heart disease
Beta‐blocker showed no clear difference in bradycardia—cardiac surgery ECG compared with control—cardiac surgery (low certainty).
1 finding from 1 review
Hypotension—cardiac surgery · patients with coronary heart disease and/or valvular heart disease
Beta‐blocker showed no clear difference in hypotension—cardiac surgery compared with control—cardiac surgery (low certainty).
1 finding from 1 review
Blood loss requiring further surgery (intraoperatively and postoperatively) · adults undergoing non‐cardiac surgery
Continuation showed no clear difference in blood loss requiring further surgery (intraoperatively and… compared with discontinuation of antiplatelet therapy (low certainty).
1 finding from 1 review
Ischaemic events: peripheral thrombosis, cerebral myocardial infarction (within 30 days of surgery) · adults undergoing non‐cardiac surgery
Continuation showed no clear difference in ischaemic events: peripheral thrombosis, cerebral myocardial… compared with discontinuation of antiplatelet therapy (low certainty).
1 finding from 1 review
Intervention not reported
Treatment 1: combined prophylaxis (topical regimen + periocular penicillin at the time of surgery) · participants undergoing cataract surgery
1 finding from 1 review
no estimate extracted
6618 participants
Moderate
Intervention not reported
Epilepsy Surgery Outcome Engel Class Outcome · patients undergoing epilepsy surgery with medically refractory epilepsy
1 finding from 1 review
Intervention not reported
ILAE Epilepsy Surgery Outcome · patients undergoing epilepsy surgery with medically refractory epilepsy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Composite endpoint (including all‐cause mortality, non‐fatal myocardial infarction and/or any new stroke assessed at 30 days after surgery) · people undergoing CABG (with or without valve surgery)
RIPC showed no clear difference in composite endpoint (including all‐cause mortality, non‐fatal… compared with no RIPC (moderate certainty).
1 finding from 1 review
cTnT 72 h after surgery (ng/L) · people undergoing CABG (with or without valve surgery)
RIPC showed no clear difference in cTnT 72 h after surgery (ng/L) compared with no RIPC (moderate certainty).
1 finding from 1 review
cTnI 72 h after surgery (ng/L) · people undergoing CABG (with or without valve surgery)
RIPC showed no clear difference in cTnI 72 h after surgery (ng/L) compared with no RIPC (moderate certainty).
1 finding from 1 review
Time to readiness for surgery2 (minutes) · Adult patients undergoing hand, wrist or forearm surgery
1 finding from 1 review
Time to readiness for surgery2 (minutes) · Adult patients undergoing hand, wrist or forearm surgery
1 finding from 1 review
Time to readiness for surgery2 (minutes) · Adult patients undergoing hand, wrist or forearm surgery
1 finding from 1 review
Poor vision due to MO at 3 months after surgery · patients undergoing cataract surgery
NSAIDS plus steroids may leads to lower poor vision due to MO at 3 months after surgery compared with steroids (low certainty).
1 finding from 1 review